Cigna Corporation
CI
position
long
Larry Robbins
Thesis
Cigna is trading at 8x earnings, which is exceedingly cheap compared to its growth potential. The company is expected to benefit from the influx of uninsured individuals entering the market in 2014 due to healthcare reform, which should positively impact its customer base and revenue.
Did it work?
inconclusive
confidence: low
Without specific price performance data or a defined time horizon for the thesis, it's difficult to assess whether the investment thesis has played out. While the thesis suggests a positive outlook based on growth potential and market changes, we cannot determine the actual impact on Cigna's stock price or performance. Therefore, the outcome remains uncertain.
Raw excerpt
No raw excerpt stored.